Panacea Biotec Limited
₹357.7
INR+17.00(+4.99%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹1933.68 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹1689.71 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
91.93
Forward P/E
Price to Earnings ratio based on forecasted earnings
NA
PEG Ratio
Price/Earnings to Growth ratio
NA
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.54
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
63.95%
Operating Margin
Operating income as a percentage of revenue
-16.35%
Return on Equity
Net income as a percentage of shareholders' equity
-0.14%
Revenue (TTM)
Total revenue over trailing 12 months
₹545.70 Cr-10.4%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹5.74 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹-4.590
Balance Sheet
Total Cash
Total cash and short-term investments
₹179.84 Cr
Total Debt
Total short-term and long-term debt
₹20.99 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
2.50%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹112.35 - ₹367.27
Beta
Measure of stock's volatility compared to the market
0.94
Shares Outstanding
Total number of shares issued by the company
₹6.13 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.91%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
0.00%